Why was Salvarsan an important early chemotherapeutic drug?

Salvarsan, also known as arsphenamine, was a landmark development in therapeutics because it inaugurated the chemotherapeutic era, revolutionizing the control of infectious diseases.1

Developed by Paul Ehrlich and Sahachiro Hata in 1910, the drug was significant for several reasons:

• Targeted Efficacy: Based on Ehrlich’s theory of selective affinity, Salvarsan was a synthetic preparation containing arsenic specifically designed to be lethal to the microorganism responsible for syphilis.1
• Standard of Care: Before the discovery of penicillin, Salvarsan and its modifications served as the primary, standard treatment for syphilis.1
• Public Health Impact: By providing an effective medical intervention, it played a critical role in bringing a major social and medical scourge under control.1

This success validated the scientific approach of using specific chemical substances to combat disease organisms, setting the foundation for modern medicinal chemistry.1